Ultomiris

Ravulizumab-Cwvz

6.6 Moderate risk

Ultomiris & Off label use

19.5%

of users reported Off label use

71.4%

also reported Severe reaction

63.6%

are women

Most common medical consequences

Severe reaction
71.4%
Hospitalization
28.6%

Have you experienced any negative side effects from this medication?

Ultomiris: general information

Most common side effects (43)

Most commonly affected ages

20 - 29 years
23.9%
30 - 39 years
17.5%
40 - 49 years
13.4%
50 - 59 years
12.3%
60 - 69 years
10.8%
70 - 79 years
18.3%
80 - 89 years
3.7%